UBS Group’s Generation Bio GBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-164,716
| Closed | -$936K | – | 10738 |
|
|
2025
Q4 | $936K | Buy |
164,716
+15,995
| +11% | +$90.3K | ﹤0.01% | 5635 |
|
|
2025
Q3 | $910K | Buy |
148,721
+60,231
| +68% | +$312K | ﹤0.01% | 5655 |
|
|
2025
Q2 | $283K | Sell |
88,490
-9,245
| -9% | -$35.6K | ﹤0.01% | 6481 |
|
|
2025
Q1 | $396K | Sell |
97,735
-7,616
| -7% | -$53.5K | ﹤0.01% | 6037 |
|
|
2024
Q4 | $1.12M | Buy |
105,351
+20,662
| +24% | +$368K | ﹤0.01% | 5219 |
|
|
2024
Q3 | $2.09M | Buy |
84,689
+904
| +1% | +$23.9K | ﹤0.01% | 3946 |
|
|
2024
Q2 | $2.36M | Sell |
83,785
-3,025
| -3% | -$98.3K | ﹤0.01% | 3595 |
|
|
2024
Q1 | $3.53M | Buy |
86,810
+70
| +0.1% | +$1.65K | ﹤0.01% | 3349 |
|
|
2023
Q4 | $1.43M | Buy |
86,740
+46,979
| +118% | +$819K | ﹤0.01% | 4165 |
|
|
2023
Q3 | $1.51M | Sell |
39,761
-386
| -1% | -$18.3K | ﹤0.01% | 3722 |
|
|
2023
Q2 | $2.21M | Buy |
40,147
+1,419
| +4% | +$65.1K | ﹤0.01% | 3427 |
|
|
2023
Q1 | $1.67M | Buy |
38,728
+781
| +2% | +$37.8K | ﹤0.01% | 3620 |
|
|
2022
Q4 | $1.49M | Buy |
37,947
+753
| +2% | +$39.5K | ﹤0.01% | 3683 |
|
|
2022
Q3 | $1.98M | Buy |
37,194
+36,186
| +3,590% | +$2.26M | ﹤0.01% | 3177 |
|
|
2022
Q2 | $66K | Buy |
1,008
+390
| +63% | +$25.5K | ﹤0.01% | 5718 |
|
|
2022
Q1 | $45K | Sell |
618
-10,315
| -94% | -$598K | ﹤0.01% | 6601 |
|
|
2021
Q4 | $774K | Buy |
+10,933
| New | +$1.91M | ﹤0.01% | 4613 |
|
|
2021
Q3 | – | Sell |
-1,722
| Closed | -$463K | – | 9733 |
|
|
2021
Q2 | $463K | Sell |
1,722
-997
| -37% | -$298K | ﹤0.01% | 4788 |
|
|
2021
Q1 | $774K | Buy |
+2,719
| New | +$870K | ﹤0.01% | 4501 |
|
|
2020
Q4 | – | Sell |
-5
| Closed | -$2K | – | 8517 |
|
|
2020
Q3 | $2K | Sell |
5
-108
| -96% | -$25.8K | ﹤0.01% | 7654 |
|
|
2020
Q2 | $24K | Buy |
+113
| New | +$25.2K | ﹤0.01% | 6428 |
|
Other funds holding GBIO
UBS Group's GBIO Position: Q1 2026 in Review
UBS Group sold out of Generation Bio (GBIO) in Q1 2026, closing a stake of 164,716 shares — an estimated $936K sold.
UBS Group first reported a position in GBIO in Q2 2020 and held it in 21 quarters. The position peaked at $3.53M in Q1 2024. 2 funds tracked by Wall St. Rank hold GBIO as of Q1 2026.
- UBS Group reported no remaining Generation Bio position as of Q1 2026 after selling out during the quarter.
- UBS Group sold 164,716 Generation Bio shares in Q1 2026, an estimated $936K.
- UBS Group first reported a position in Generation Bio in Q2 2020 and held it in 21 quarters.
- UBS Group's Generation Bio position peaked at $3.53M in Q1 2024.
- 2 funds tracked by Wall St. Rank held Generation Bio as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.